These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11806989)

  • 1. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.
    Myers LA; Patel DD; Puck JM; Buckley RH
    Blood; 2002 Feb; 99(3):872-8. PubMed ID: 11806989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Patel DD; Gooding ME; Parrott RE; Curtis KM; Haynes BF; Buckley RH
    N Engl J Med; 2000 May; 342(18):1325-32. PubMed ID: 10793165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation outcomes for severe combined immunodeficiency, 2000-2009.
    Pai SY; Logan BR; Griffith LM; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Hanson IC; Filipovich AH; Jyonouchi S; Sullivan KE; Small TN; Burroughs L; Skoda-Smith S; Haight AE; Grizzle A; Pulsipher MA; Chan KW; Fuleihan RL; Haddad E; Loechelt B; Aquino VM; Gillio A; Davis J; Knutsen A; Smith AR; Moore TB; Schroeder ML; Goldman FD; Connelly JA; Porteus MH; Xiang Q; Shearer WT; Fleisher TA; Kohn DB; Puck JM; Notarangelo LD; Cowan MJ; O'Reilly RJ
    N Engl J Med; 2014 Jul; 371(5):434-46. PubMed ID: 25075835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation.
    Sarzotti M; Patel DD; Li X; Ozaki DA; Cao S; Langdon S; Parrott RE; Coyne K; Buckley RH
    J Immunol; 2003 Mar; 170(5):2711-8. PubMed ID: 12594301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
    Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A
    Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.
    Buckley RH
    Immunol Res; 2011 Apr; 49(1-3):25-43. PubMed ID: 21116871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.
    Bertrand Y; Landais P; Friedrich W; Gerritsen B; Morgan G; Fasth A; Cavazzana-Calvo M; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Haddad E; Fischer A
    J Pediatr; 1999 Jun; 134(6):740-8. PubMed ID: 10356144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive Family History, Infection, Low Absolute Lymphocyte Count (ALC), and Absent Thymic Shadow: Diagnostic Clues for All Molecular Forms of Severe Combined Immunodeficiency (SCID).
    McWilliams LM; Dell Railey M; Buckley RH
    J Allergy Clin Immunol Pract; 2015; 3(4):585-91. PubMed ID: 25824440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features and HSCT Outcome for SCID in Turkey.
    Ikinciogullari A; Cagdas D; Dogu F; Tugrul T; Karasu G; Haskologlu S; Aksoylar S; Uygun V; Kupesiz A; Yildiran A; Gursel O; Ates C; Elhan A; Kansoy S; Yesilipek A; Tezcan I;
    J Clin Immunol; 2019 Apr; 39(3):316-323. PubMed ID: 30924026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
    Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
    J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
    Heimall J; Logan BR; Cowan MJ; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Pulsipher MA; Parikh S; Martinez C; Kapoor N; O'Reilly R; Boyer M; Pai SY; Goldman F; Burroughs L; Chandra S; Kletzel M; Thakar M; Connelly J; Cuvelier G; Davila Saldana BJ; Shereck E; Knutsen A; Sullivan KE; DeSantes K; Gillio A; Haddad E; Petrovic A; Quigg T; Smith AR; Stenger E; Yin Z; Shearer WT; Fleisher T; Buckley RH; Dvorak CC
    Blood; 2017 Dec; 130(25):2718-2727. PubMed ID: 29021228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
    Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH
    J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency.
    Borghans JA; Bredius RG; Hazenberg MD; Roelofs H; Jol-van der Zijde EC; Heidt J; Otto SA; Kuijpers TW; Fibbe WE; Vossen JM; Miedema F; van Tol MJ
    Blood; 2006 Jul; 108(2):763-9. PubMed ID: 16822903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output.
    Pirovano S; Notarangelo LD; Malacarne F; Mazzolari E; Porta F; Lanfranchi A; Giliani S; Zucca S; Pecorelli S; Albertini A; Ugazio AG; Imberti L
    Haematologica; 2004 Apr; 89(4):450-61. PubMed ID: 15075079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.
    Olkinuora H; von Willebrand E; Kantele JM; Vainio O; Talvensaari K; Saarinen-Pihkala U; Siitonen S; Vettenranta K
    Scand J Immunol; 2011 Jun; 73(6):586-93. PubMed ID: 21323694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years.
    Kwan A; Church JA; Cowan MJ; Agarwal R; Kapoor N; Kohn DB; Lewis DB; McGhee SA; Moore TB; Stiehm ER; Porteus M; Aznar CP; Currier R; Lorey F; Puck JM
    J Allergy Clin Immunol; 2013 Jul; 132(1):140-50. PubMed ID: 23810098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency.
    Tuckett AZ; Thornton RH; O'Reilly RJ; van den Brink MRM; Zakrzewski JL
    J Hematol Oncol; 2017 May; 10(1):109. PubMed ID: 28511686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via In utero or postnatal transfer.
    Blazar BR; Taylor PA; McElmurry R; Tian L; Panoskaltsis-Mortari A; Lam S; Lees C; Waldschmidt T; Vallera DA
    Blood; 1998 Nov; 92(10):3949-59. PubMed ID: 9808589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
    Knutsen AP; Wall DA
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.